Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 74 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

Tradez Bristol Myers BMY

Vendre
 Acheter

 Graphique en direct de BristolMyers

5m 15m 30m 1h 4h 1d 1w

Principes de base des instruments

Weekly Search
Weekly
Daily
Date Fermer Changes % Variation Ouvrir un compte Haut Bas

Dernières nouvelles

Closing 2024
2024 Dec 26, 17:00

Semaine à venir : Clôture de l’année 2024 et premières données économiques de 2025

UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Semaine à venir : Dernière semaine complète de 2024 sur les marchés financiers

Le Forex Indices
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Semaine à venir : Les taux d'intérêt américains et l'inflation en Europe déterminent l'orientation des marchés

Indices Le Forex
Dyogenes Diniz 2024 Dec 05, 16:00

Semaine à venir : L'inflation et les taux d'intérêt vont secouer les marchés cette semaine

Le Forex Indices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Semaine à venir :  L'emploi aux États-Unis devrait influencer le sentiment des marchés cette semaine.

Le Forex Indices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Semaine à venir : L'inflation de la zone euro devrait confirmer une réduction des taux de la BCE en décembre

Le Forex Indices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Semaine à venir : La hausse de la tech table sur les résultats de Nvidia

Le Forex Indices
Markets.com Support Team 2024 Nov 07, 16:00

Semaine à venir : « Trump trade », données sur l'inflation, résultats de Disney

Le Forex Indices

Info

Spread

0.31

Spread (%)

0.6164 %

Effet de levier

1:5

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Vendredi

13:31 - 19:59

Lundi

13:31-19:59

Mardi

13:31-19:59

Mercredi

13:31-19:59

Jeudi

13:31-19:59

Analyse et statistiques

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

103182671872

Actions en circulation

2034759936

Date de rapport d'activité (suivante)

2001-08-07

Rendement des div

2025-05-01

Date de détachement du dividende

2025-04-04

Le taux de dividende annuel à terme 

2.48

Le rendement de dividende annuel à terme

0.0489

EPS

-4.41

En savoir plus sur cet instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Instruments connexes

Actif
Vendre
Acheter
% Variation

Tradez

Tradez

Tradez

Tradez
Instruments connexes
Trustpilot
RequestMessages5TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version30.71msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
30.88ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=th; mktloc=eyJpdiI6IllhTTl0ZnRJT0hDelNJNWlRaDdObUE9PSIsInZhbHVlIjoicjhxa0VBMlFPc25hcTgzbytyK3RCZXNSc1FUYW1KbXR3ZXQ0STlJWDIvNHl1bk9zeHQ4ZjN1ZXI4dEZYWWlqciIsIm1hYyI6IjIzZjViZDU4ZjE3MGU0MGQwNTViMTg5ZTczNjA0ZDFhMTU0OWEzN2Q3YTIzNGFlNGZjMzk1M2E2MWVlNTU2MjIiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fid%252Finstrument%252Fphilipmorris%252F; intent_instrument=philipmorris; firstURL=https://web-qa.staging.markets.com/pt/instrument/digitalworld/; lastURL=https://web-qa.staging.markets.com/pt/instrument/digitalworld/; XSRF-TOKEN=eyJpdiI6ImpKQ1lQWnlLc0lGM2g2M3RManhkZHc9PSIsInZhbHVlIjoidGRSYUtLbCtOdGc5enVxT0dubEpKSHYrOHdoaG1pQmdVOG1lVnZiaDNYRG41OXNZbG9rWVk4cjZWTXlUaThIekY3cXBrZ2hTRmViV1EwaWJlU3d1TXhZZCtBVVplbjExd3B6djJYQlV1SDlET3R3NnpYTVlhRWFZQitlWGM5R3UiLCJtYWMiOiJiN2Q2ZDViMTBiMzllZmU3MjIxZGFhMTNlYTU2NTFmZDhlNjk1NzEwZmIwYzI0ZDdiOWYwYWNhNzliYzM0NzI5IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6Im13eUowSncvQ21CN05KMU9PTHY5bVE9PSIsInZhbHVlIjoiRW9MelgyMFdVeGdrTnhPSXRncnVsVnN0THJCK3g1dG44RWcyd1h3eTVZa0pmeXRMZC9zbmNRdEUvYmxTNzRCNWIrODViTklLRUd4QzVZaERtaDhRY0hEYVorTXdVZ1pBTFcrSEtrU2xFRitoL0EzOVd4d1RldlgzdWZYN1MxK0IiLCJtYWMiOiIwNjE1ZGQ5Yjg3NWQ3ZDJkMDAxMzU3MTcyZmE5ZGEzNzkzZTkzMzhhZDhkM2U0OTgyMDI1MjI4NmE1OTg4ZThiIiwidGFnIjoiIn0%3D ◀mktv4_ip_override=th; mktloc=eyJpdiI6IllhTTl0ZnRJT0hDelNJNWlRaDdObUE9PSIsInZhbHVlIjoicjhxa0VBMlFPc25hcTgzbytyK3RCZXNSc1FUYW1KbXR3ZXQ0STlJWDIvNHl1bk9zeHQ4ZjN1ZXI ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktv4_ip_override" => null
  "mktloc" => "us,us"
  "intent_group" => null
  "intent_instrument" => null
  "firstURL" => null
  "lastURL" => null
  "XSRF-TOKEN" => "9vUXjZ321AiQtbDlsHnPwaSlvQfzd7B4t28DQMEJ"
  "laravel_session" => "znpEWkRhZ1KCamrh7luVxUUnCohiPU6FIkF0XDHC"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Mon, 14 Apr 2025 14:13:23 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "9vUXjZ321AiQtbDlsHnPwaSlvQfzd7B4t28DQMEJ"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/csrf"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (12.98ms)time
    • Application (17.71ms)time
    • Routing (484μs)
    • 1 x Application (57.68%)
      17.71ms
      1 x Booting (42.28%)
      12.98ms
      1 x Routing (1.58%)
      484μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              9vUXjZ321AiQtbDlsHnPwaSlvQfzd7B4t28DQMEJ
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-14 14:13:20GET/fr/instrument/bristolmyers/567
              #22025-04-14 14:13:23GET/csrf/ (ajax)
              #32025-04-14 14:13:23GET/params/ (ajax)